Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Dividends Paid - Common (2016 - 2025)

Conmed (CNMD) has disclosed Dividends Paid - Common for 14 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Dividends Paid - Common changed 0.23% year-over-year to $6.2 million, compared with a TTM value of $24.7 million through Dec 2025, changed 0.39%, and an annual FY2025 reading of $24.7 million, changed 0.39% over the prior year.
  • Dividends Paid - Common was $6.2 million for Q4 2025 at Conmed, roughly flat from $6.2 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $6.2 million in Q4 2025 and bottomed at $5.8 million in Q1 2021.
  • Average Dividends Paid - Common over 5 years is $6.1 million, with a median of $6.1 million recorded in 2023.
  • The sharpest move saw Dividends Paid - Common increased 4.49% in 2022, then increased 0.23% in 2025.
  • Year by year, Dividends Paid - Common stood at $5.8 million in 2021, then grew by 4.4% to $6.1 million in 2022, then increased by 0.89% to $6.1 million in 2023, then increased by 0.46% to $6.2 million in 2024, then increased by 0.23% to $6.2 million in 2025.
  • Business Quant data shows Dividends Paid - Common for CNMD at $6.2 million in Q4 2025, $6.2 million in Q3 2025, and $6.2 million in Q2 2025.